Publication | Closed Access
12-months prospective Pentraxin-3 and metabolomic evaluation in multiple sclerosis patients treated with glatiramer acetate
19
Citations
22
References
2020
Year
12-Months Prospective Pentraxin-3Multiple Sclerosis PatientsNeurobiology Of DiseaseNeurological DisorderNeurochemical BiomarkersNeurologyMultiple SclerosisMedicineGlatiramer AcetateNeuroinflammation
| Year | Citations | |
|---|---|---|
Page 1
Page 1